Company Search:
Advanced Search
Sponsored Links
Tella Incorporation Company Snapshot
Tella Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tella Incorporation with three other companies in this sector in Japan: Human Metabolome Technologies Inc (2017 sales of 914.18 million Japanese Yen [US$8.04 million] ), SanBio Co Ltd (949.54 million Japanese Yen [US$8.36 million] of which 100% was Commercial Physical Research), and Gene Techno Science Co Ltd (1.09 billion Japanese Yen [US$9.59 million] of which 100% was Drug Development).

Sales Analysis. Tella Incorporation reported sales of ¥957.64 million (US$8.43 million) for the year ending December of 2017. This represents a sharp decrease of 46.9% versus 2016, when the company's sales were ¥1.80 billion. Contributing to the drop in overall sales was the 55.9% decline in Cell Therapy Support Business, from ¥994.76 million to ¥439.14 million. There were also decreases in sales in Cell Therapy Technology Development Busi (down 35.8% to ¥518.51 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tella Incorporation
  Stock Performance Chart for Tella Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): 270.00
(Figures in Japanese Yen)
1 Week -2.9%   13 Weeks -15.1%  
4 Weeks 21.1%   52 Weeks -47.7%  
Tella Incorporation Key Data:
  Ticker: 2191 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 957,644,000
(Year Ending Jan 2018).
Employees: 29
  Currency: Japanese Yen Market Cap: 4,700,376,810
  Fiscal Yr Ends: December Shares Outstanding: 17,408,803
  Share Type: Common Closely Held Shares: 1,963,823
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.